ALC 📈 Alcon - Overview

Exchange: NYSE • Country: Switzerland • Currency: USD • Type: Common Stock • ISIN: CH0432492467

ALC: Contact Lenses, Surgical Instruments, Implantables, Vitamins, Eye Drops

Alcon AG is a global medical company that specializes in the development, manufacturing, and distribution of eye care products, catering to the needs of eye care professionals and their patients worldwide. The company operates through two primary segments: Surgical and Vision Care. The Surgical segment offers an extensive range of products, including equipment, instrumentation, and diagnostics for surgical procedures, as well as intraocular lenses and other implantables. This segment also provides consumables such as viscoelastics, surgical solutions, and incisional instruments, which are essential for various surgical procedures.

Within the Surgical segment, Alcon AG offers a variety of cataract products, including the Centurion vision system, LenSx laser system, and ARGOS biometer, which are designed to enhance the precision and efficiency of cataract surgeries. Additionally, the company provides custom pak surgical procedure packs, vitreoretinal products, and refractive surgery products, such as WaveLight lasers and Contoura Vision, which are used for LASIK treatment. The company also offers implantable products, including AcrySof IQ products, which are designed to correct presbyopia and astigmatism during cataract surgery. Other notable products in this segment include the EX-PRESS glaucoma filtration device and the ORA system for intra-operative measurements.

The Vision Care segment of Alcon AG focuses on providing a range of products for the care and maintenance of vision, including daily disposable, reusable, and color-enhancing contact lenses. The company also offers ocular health products, such as dry eye treatments, glaucoma medications, and contact lens care solutions, as well as ocular vitamins and redness relievers. These products are designed to promote eye health and provide relief from various ocular conditions, ultimately enhancing the quality of life for individuals with vision impairments.

With a rich history dating back to 1945, Alcon AG has established itself as a leading player in the eye care industry, with a strong presence in the global market. The company, formerly known as Alcon Universal S.A., changed its name to Alcon Inc. in December 2001 and is currently headquartered in Geneva, Switzerland. As a publicly traded company listed on the NYSE under the ticker symbol ALC, Alcon AG is committed to delivering innovative eye care solutions that meet the evolving needs of eye care professionals and their patients worldwide.

Additional Sources for ALC Stock

ALC Stock Overview

Market Cap in USD 43,093m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Health Care Equipment
IPO / Inception 2019-04-09

ALC Stock Ratings

Growth 5y 53.9%
Fundamental 47.6%
Dividend 45.6%
Rel. Strength Industry 168
Analysts 4.37/5
Fair Price Momentum 76.90 USD
Fair Price DCF 56.56 USD

ALC Dividends

Dividend Yield 12m 0.31%
Yield on Cost 5y 0.47%
Annual Growth 5y 3.97%
Payout Consistency 99.4%

ALC Growth Ratios

Growth Correlation 3m -93%
Growth Correlation 12m 70.8%
Growth Correlation 5y 75.5%
CAGR 5y 8.42%
CAGR/Mean DD 5y 0.80
Sharpe Ratio 12m 0.34
Alpha -13.14
Beta 0.88
Volatility 24.17%
Current Volume 917.6k
Average Volume 20d 839.5k
What is the price of ALC stocks?
As of December 21, 2024, the stock is trading at USD 84.76 with a total of 917,602 shares traded.
Over the past week, the price has changed by +0.70%, over one month by -0.87%, over three months by -13.05% and over the past year by +13.78%.
Is Alcon a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Alcon (NYSE:ALC) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.60 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALC as of December 2024 is 76.90. This means that ALC is currently overvalued and has a potential downside of -9.27%.
Is ALC a buy, sell or hold?
Alcon has received a consensus analysts rating of 4.37. Therefor, it is recommend to buy ALC.
  • Strong Buy: 16
  • Buy: 6
  • Hold: 4
  • Sell: 1
  • Strong Sell: 0
What are the forecast for ALC stock price target?
According to ValueRays Forecast Model, ALC Alcon will be worth about 84.7 in December 2025. The stock is currently trading at 84.76. This means that the stock has a potential downside of -0.07%.
Issuer Forecast Upside
Wallstreet Target Price 100.2 18.2%
Analysts Target Price 93.3 10.1%
ValueRay Target Price 84.7 -0.1%